Search

Chinese
Resource Library / Validation of Ultra-high Sensitive SIMOA Assays for the Quantitation of NF-L and GFAP

poster

Validation of Ultra-high Sensitive SIMOA Assays for the Quantitation of NF-L and GFAP

In this poster, we validate ultra-high sensitive SIMOA assays for the successful quantitation of neurofilament light chain (NF-L) and glial fibrillary acidic protein (GFAP).

Resources to Consider

Left arrow
Method Validation of Quantitation IL-17A in Human Serum using the Ultrasensitive Quanterix Simoa™ Platform
poster

Method Validation of Quantitation IL-17A in Human Serum using the...
Interleukin17A (IL-17A) is disulfide-linked homo dimeric cytokine of 155 amino acids and a...
Access Resource
An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous Determination…
journal

An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous...
An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous Determination of Ciclesonide and A...
Access Resource
Achieving sensitive and specific oligonucleotide quantification by hybrid immunoassay and LC–MS/MS
webinar

Achieving sensitive and specific oligonucleotide quantification by...
Oligonucleotide (OGN) therapy is increasingly recognized as an important therapeutic modal...
Access Resource
Development and Validation of an Ultra Sensitive LC-MS/MS Method for Quantitation of Midazolam in Human Plasma
poster

Development and Validation of an Ultra Sensitive LC-MS/MS Method for...
Midazolam is a widely used central nervous system depressant. It is used for the treatment...
Access Resource
Neurofilament Light Chain: Method Validation of Quantitation Using the Quanterix Simoa™ Platform and Potential Applications
poster

Neurofilament Light Chain: Method Validation of Quantitation Using...
In this study, we quantify Neurofilament Light Chain (NF-L) in human plasma, serum, and CS...
Access Resource
Validating The Simoa Technology
white-paper

Validating The Simoa Technology
The Simoa system is ultra-sensitive, and capable of detecting and quantifying challenging ...
Access Resource
Immunoassays for Drug Discovery
fact-sheet

Immunoassays for Drug Discovery
Frontage supports early drug discovery with various immunoassays for proteins and therapeu...
Access Resource
Utilizing Ligand Binding Assays (LBA) and Critical Reagents for Drug Development
panel-discussion

Utilizing Ligand Binding Assays (LBA) and Critical Reagents for Drug...
Critical reagents – the key components used in LBA – are central to ensuring the consi...
Access Resource
Ligand Binding Assays (LBAs) and Critical Reagents
infographic

Ligand Binding Assays (LBAs) and Critical Reagents
In this infographic, we explore the current landscape of ligand binding assays (LBAs) and ...
Access Resource
Sequencing Assays for Biomarker Discovery and Pharmacodynamics in Oncology Studies eBook
ebook

Sequencing Assays for Biomarker Discovery and Pharmacodynamics in...
In this eBook, we navigate the landscape of biomarker discovery through genomic profiling,...
Access Resource
Biomarker and Alzheimer’s disease: role of high sensitivity assays and the applications
webinar

Biomarker and Alzheimer’s disease: role of high sensitivity...
It has been said that the diagnosis of Alzheimer's disease enters the era of biomarkers. T...
Access Resource
Empowering immune monitoring with ELISpot assays
webinar

Empowering immune monitoring with ELISpot assays
The emergence of global pandemics has led to an expansion of studies focused on vaccine de...
Access Resource
Right arrow